Literature DB >> 11465558

Roles of carbon monoxide in leukocyte and platelet dynamics in rat mesenteric during sevoflurane anesthesia.

H Morisaki1, T Katayama, Y Kotake, M Ito, T Tamatani, S Sakamoto, Y Ishimura, J Takeda, M Suematsu.   

Abstract

BACKGROUND: Heme oxygenase 1 (HO-1), induced by a variety of stressors, provides endogenous carbon monoxide (CO) and bilirubin, both of which play consequential roles in organs. The current study aimed to examine whether induction of HO-1 and its by-products modulated endothelial interaction with circulating leukocytes and platelets evoked by sevoflurane anesthesia in vivo.
METHODS: Rats, pretreated with or without hemin, were anesthetized with sevoflurane in 100% O2, and lungs were mechanically ventilated. Platelets labeled with carboxyfluorescein diacetate succinimidyl ester and leukocyte behavior in mesenteric venules were visualized during sevoflurane anesthesia at 1,000 frames/s using intravital ultrahigh-speed intensified fluorescence videomicroscopy. To examine the mechanisms for the effects of HO-1 on leukocyte and platelet behavior, these studies were repeated with superfusion of either CO, bilirubin, or Nomega-nitro-L-arginine methyl ester (L-NAME).
RESULTS: As reported previously, the elevation of sevoflurane concentration evoked adhesive responses of leukocytes, concurrent with platelet margination and rolling. Pretreatment with hemin, a HO-1 inducer, prevented such sevoflurane-elicited changes in the microvessels. These changes were restored by zinc protoporphyrin IX, a HO inhibitor, and repressed by CO but not by bilirubin. During sevoflurane anesthesia, however, nitric oxide suppression by L-NAME deteriorated microvascular flows irrespective of the presence or absence of the HO-1 induction.
CONCLUSIONS: These results indicate that endogenous CO via HO-1 induction attenuates sevoflurane-induced microvascular endothelial interactions with leukocytes and platelets, although local nitric oxide levels appear to dominate microvascular flow in situ.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11465558     DOI: 10.1097/00000542-200107000-00030

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  5 in total

1.  A single dose of carbon monoxide intraperitoneal administration protects rat intestine from injury induced by lipopolysaccharide.

Authors:  Shao-Hua Liu; Ke Ma; Xin-Rong Xu; Bing Xu
Journal:  Cell Stress Chaperones       Date:  2010-03-27       Impact factor: 3.667

2.  Reduction of ICAM-1 expression by carbon monoxide via soluble guanylate cyclase activation accounts for modulation of neutrophil migration.

Authors:  Daniela Dal-Secco; Andressa Freitas; Monica A Abreu; Thiago P Garlet; Marcos A Rossi; Sérgio H Ferreira; João S Silva; José C Alves-Filho; Fernando Q Cunha
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-27       Impact factor: 3.000

3.  Ex vivo carbon monoxide delivery inhibits intimal hyperplasia in arterialized vein grafts.

Authors:  Atsunori Nakao; Chien-Sheng Huang; Donna B Stolz; Yinna Wang; Jonathan M Franks; Naobumi Tochigi; Timothy R Billiar; Yoshiya Toyoda; Edith Tzeng; Kenneth R McCurry
Journal:  Cardiovasc Res       Date:  2010-09-16       Impact factor: 10.787

Review 4.  Role of carbon monoxide in cardiovascular function.

Authors:  William Durante; Fruzsina K Johnson; Robert A Johnson
Journal:  J Cell Mol Med       Date:  2006 Jul-Sep       Impact factor: 5.310

Review 5.  Protective effect of carbon monoxide in transplantation.

Authors:  Atsunori Nakao; Augustine M K Choi; Noriko Murase
Journal:  J Cell Mol Med       Date:  2006 Jul-Sep       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.